Halvard & Pike Apothecary of Portland, Maine enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Enforcement Dispatch
The observation that closes a facility is rarely the dramatic one.
Inspectors have cited Halvard & Pike Apothecary of Portland, Maine over sterility assurance at its sterile-preparation suite, according to an inspection report reviewed by the Journal. The observations include an inadequate media-fill programme, environmental monitoring excursions closed without investigation, and a quality unit whose reporting line ran to the production manager rather than independently.
The observations, in the order the report lists them: media fills not performed at the required frequency; smoke studies not repeated after a change to the airflow configuration; 18 environmental monitoring excursions closed without a documented investigation; personnel gowning qualification records incomplete for two operators; and a quality unit lacking independent authority to reject a batch.
The letter records that the firm was given 9 days to respond to the initial observations and did so, that the response was found inadequate in respect of 18 of the observations, and that the specific inadequacy was a corrective action plan without a root-cause analysis. That sequence — observation, response, response found inadequate, letter — is the ordinary path and takes months.
Enforcement in this sector is slow by design: inspection, observation, response, escalation, letter, and only then injunction or decree. The consequence is that a facility with a serious quality problem can continue operating for a year or more while the process runs, and that the closure, when it comes, appears sudden to everyone outside it.
"A batch range instead of a lot list is a decision," said Dr Wenjun Xie, process chemist and peptide manufacturing consultant. "It is cheaper for the company and it transfers the work to every pharmacist holding stock."
"A batch range instead of a lot list is a decision," said Dr Adaeze Nwafor, consultant endocrinologist, Leeds. "It is cheaper for the company and it transfers the work to every pharmacist holding stock."
This action has been added to the Journal’s running index of compounding-related enforcement, which records the date of inspection, the observations, the response and the outcome for every action we have been able to document.
Halvard & Pike Apothecary of Portland, Maine is not connected with any of the manufacturers or suppliers profiled in the Journal’s vendor dossiers.
The observation that closes a facility is rarely the dramatic one.
The document is four pages. Three of them are about dates.
Reported from the analysis, not from a warning notice.
The observation that closes a facility is rarely the dramatic one.
The document is four pages. Three of them are about dates.
The observation that closes a facility is rarely the dramatic one.